Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

On the Call: Abbott acquisitions in 2010
Yahoo/AP
Wednesday, April 21, 2010 - 3:48pm
tags:
Abbott Laboratories, M&A, Evalve, Solvay, Advanced Medical Optics
How Big Pharma Will Survive the Patent Cliff
Minyanville
Wednesday, April 21, 2010 - 3:47pm
tags:
Big Pharma, patents
Genzyme to pay FDA $175m in settlement
Bizjournals.com
Wednesday, April 21, 2010 - 10:59am
tags:
FDA, settlements, Genzyme
Will The Drugs Ever Work For Elan?
WSJ Online
Wednesday, April 21, 2010 - 10:57am
tags:
Elan, Tysabri
Boehringer-Ingelheim Pays $8M To Settle Fraud
Pharmalot
Wednesday, April 21, 2010 - 10:56am
tags:
Boehringer Ingelheim, fraud, Medicaid
Merck inks deal on tetanus, diphtheria vaccine
Yahoo/AP
Wednesday, April 21, 2010 - 10:54am
tags:
Merck, partnerships, vaccines, Mass Biologics, tetanus, diphtheria
When Heart Devices Fail, Who Should Be Blamed?
NY Times, NY
Wednesday, April 21, 2010 - 10:50am
tags:
Guidant, devices, Boston Scientific, defibrillators
District Court Denies Teva's Motion to Stay Integrelin Case
Seeking Alpha
Wednesday, April 21, 2010 - 10:27am
tags:
Teva Pharmaceuticals, Integrilin, ANDAs, Millennium
New Novartis chief talks productivity
Fierce Pharma
Wednesday, April 21, 2010 - 10:25am
tags:
Novartis, reorganization, Joe Jimenez, Pharma CEOs
One Strategic Purchase Makes Pharma Shine (Warner Chilcott)
Investors.com
Wednesday, April 21, 2010 - 10:23am
tags:
Warner Chilcott
New Rules on Medicaid Discounts a Bummer for States
WSJ Online
Wednesday, April 21, 2010 - 9:56am
tags:
Medicaid, healthcare reform
Gilead leads drug stocks south
Marketwatch
Wednesday, April 21, 2010 - 9:55am
tags:
Gilead Sciences, drug stocks
Elan moves closer to profitability
FT.com
Wednesday, April 21, 2010 - 9:53am
tags:
Elan, earnings
[video]Sinovac Biotech: China Watch
TheStreet.com
Wednesday, April 21, 2010 - 9:46am
tags:
Sinovac, China, biotech
Valeant to Acquire Pharmaceutical Company in Brazil
Yahoo
Wednesday, April 21, 2010 - 9:44am
tags:
Valeant Pharmaceuticals, Brazil, M&A
Rexahn Should Run Again
Seeking Alpha
Wednesday, April 21, 2010 - 9:38am
tags:
Rexahn, Teva Pharmaceuticals, Serdaxin
Abbott reports lower profit due to year-ago gain
Marketwatch
Wednesday, April 21, 2010 - 9:37am
tags:
Abbott Laboratories, earnings
Human Genome Sciences Down, But Not Out
Seeking Alpha
Wednesday, April 21, 2010 - 7:56am
tags:
Human Genome Sciences, GSK, Benlysta
NicOx Shares Rise as Natixis Sees Promise in Arthritis Therapy
Bloomberg
Wednesday, April 21, 2010 - 7:55am
tags:
NicOx, arthritis
Gilead Sags Despite Q1 Beat; Sees Cost from Health Reform
Barron's
Wednesday, April 21, 2010 - 7:53am
tags:
Gilead Sciences, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.